Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 16, 2021 Filed Apr 21, 2021 01:15 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionOption (Right to Buy) · Derivative | 550,000 | Not disclosed Strike: $2.70 | Not disclosed |
DisclosureSEC source: 0001209191-21-027700 · doc4.xml · derivative · entry 3 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 550,000 shares Expires 2021-04-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not applicable. F2 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
| April 16, 2021 Filed Apr 21, 2021 01:15 UTC |
Greenman William MarinerDirector · President and CEO
|
Tax withholdingCommon Stock | 233,859 | $6.35 | $1,485,004.65 |
DisclosureSEC source: 0001209191-21-027700 · doc4.xml · nonDerivative · entry 2 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,418,672 F1 · shares: Represents a net exercise of outstanding stock options. These shares were withheld by Issuers for payment of the exercise price, based on the market price of Issuers common stock on April 15, 2021 of $6.35 in accordance with the terms of the Issuers Amended and Restated 2008 Equity Incentive Plan. The Reporting Person elected to pay the withholding taxes in cash. Read SEC document |
| April 16, 2021 Filed Apr 21, 2021 01:15 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionCommon Stock | 550,000 | $2.70 | $1,485,000.00 |
DisclosureSEC source: 0001209191-21-027700 · doc4.xml · nonDerivative · entry 1 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,652,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:43 UTC |
Jayaraman Vivek KChief Operating Officer
|
SaleCommon Stock | 15,807 | $6.38 | $100,812.30 |
DisclosureSEC source: 0001209191-21-021160 · doc4.xml · nonDerivative · entry 6 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,639 F3 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:43 UTC |
Jayaraman Vivek KChief Operating Officer
|
SaleCommon Stock | 15,786 | $6.38 | $100,678.37 |
DisclosureSEC source: 0001209191-21-021160 · doc4.xml · nonDerivative · entry 4 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,546 F3 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:43 UTC |
Jayaraman Vivek KChief Operating Officer
|
SaleCommon Stock | 5,556 | $6.38 | $35,434.50 |
DisclosureSEC source: 0001209191-21-021160 · doc4.xml · nonDerivative · entry 2 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,332 F3 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:37 UTC |
Greenman William MarinerDirector · President and CEO
|
SaleCommon Stock | 52,484 | $6.38 | $334,727.21 |
DisclosureSEC source: 0001209191-21-021140 · doc4.xml · nonDerivative · entry 6 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,102,531 F3 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:37 UTC |
Greenman William MarinerDirector · President and CEO
|
SaleCommon Stock | 76,272 | $6.38 | $486,439.93 |
DisclosureSEC source: 0001209191-21-021140 · doc4.xml · nonDerivative · entry 4 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050,652 F3 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:37 UTC |
Greenman William MarinerDirector · President and CEO
|
SaleCommon Stock | 27,651 | $6.38 | $176,349.78 |
DisclosureSEC source: 0001209191-21-021140 · doc4.xml · nonDerivative · entry 2 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 975,257 F3 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:39 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 7,989 | $6.38 | $50,951.45 |
DisclosureSEC source: 0001209191-21-021146 · doc4.xml · nonDerivative · entry 6 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,740 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:39 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 15,786 | $6.38 | $100,678.37 |
DisclosureSEC source: 0001209191-21-021146 · doc4.xml · nonDerivative · entry 4 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,959 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:39 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 5,556 | $6.38 | $35,434.50 |
DisclosureSEC source: 0001209191-21-021146 · doc4.xml · nonDerivative · entry 2 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,745 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:34 UTC |
CORASH LAURENCE MChief Scientific Officer
|
SaleCommon Stock | 7,989 | $6.38 | $50,951.45 |
DisclosureSEC source: 0001209191-21-021134 · doc4.xml · nonDerivative · entry 5 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,957,386 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:34 UTC |
CORASH LAURENCE MChief Scientific Officer
|
SaleCommon Stock | 15,786 | $6.38 | $100,678.37 |
DisclosureSEC source: 0001209191-21-021134 · doc4.xml · nonDerivative · entry 3 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,942,605 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:29 UTC |
Jensen ChrystalChief Legal Officer
|
SaleCommon Stock | 7,989 | $6.38 | $50,951.45 |
DisclosureSEC source: 0001209191-21-021131 · doc4.xml · nonDerivative · entry 6 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,853 F3 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:29 UTC |
Jensen ChrystalChief Legal Officer
|
SaleCommon Stock | 15,786 | $6.38 | $100,678.37 |
DisclosureSEC source: 0001209191-21-021131 · doc4.xml · nonDerivative · entry 4 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,072 F3 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:29 UTC |
Jensen ChrystalChief Legal Officer
|
SaleCommon Stock | 5,556 | $6.38 | $35,434.50 |
DisclosureSEC source: 0001209191-21-021131 · doc4.xml · nonDerivative · entry 2 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,858 F3 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:32 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 20,000 | $6.34 | $126,780.00 |
DisclosureSEC source: 0001209191-21-021133 · doc4.xml · nonDerivative · entry 7 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,035 F4 · price: This transaction was executed pursuant to a 10b5-1 plan.The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.29 to $6.42 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:32 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 7,989 | $6.38 | $50,951.45 |
DisclosureSEC source: 0001209191-21-021133 · doc4.xml · nonDerivative · entry 6 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,035 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:32 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 15,786 | $6.38 | $100,678.37 |
DisclosureSEC source: 0001209191-21-021133 · doc4.xml · nonDerivative · entry 4 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,254 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:32 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 5,556 | $6.38 | $35,434.50 |
DisclosureSEC source: 0001209191-21-021133 · doc4.xml · nonDerivative · entry 2 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,040 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:25 UTC |
Moore CarolSVP Reg. & Quality
|
SaleCommon Stock | 7,989 | $6.38 | $50,951.45 |
DisclosureSEC source: 0001209191-21-021130 · doc4.xml · nonDerivative · entry 6 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,555 F3 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:25 UTC |
Moore CarolSVP Reg. & Quality
|
SaleCommon Stock | 15,786 | $6.38 | $100,678.37 |
DisclosureSEC source: 0001209191-21-021130 · doc4.xml · nonDerivative · entry 4 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,774 F3 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:25 UTC |
Moore CarolSVP Reg. & Quality
|
SaleCommon Stock | 5,556 | $6.38 | $35,434.50 |
DisclosureSEC source: 0001209191-21-021130 · doc4.xml · nonDerivative · entry 2 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,560 F3 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:43 UTC |
Jayaraman Vivek KChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 42,900 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021160 · doc4.xml · derivative · entry 9 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,100 Underlying: Common Stock · 42,900 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F8 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. F8 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:43 UTC |
Jayaraman Vivek KChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021160 · doc4.xml · derivative · entry 8 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:43 UTC |
Jayaraman Vivek KChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 15,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021160 · doc4.xml · derivative · entry 7 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:43 UTC |
Jayaraman Vivek KChief Operating Officer
|
Exercise / conversionCommon Stock | 42,900 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021160 · doc4.xml · nonDerivative · entry 5 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,446 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:43 UTC |
Jayaraman Vivek KChief Operating Officer
|
Exercise / conversionCommon Stock | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021160 · doc4.xml · nonDerivative · entry 3 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:43 UTC |
Jayaraman Vivek KChief Operating Officer
|
Exercise / conversionCommon Stock | 15,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021160 · doc4.xml · nonDerivative · entry 1 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · balance_after: Includes 3,052 shares purchased under Issuer's Employee Stock Purchase Plan on 02/28/21. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:37 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 104,363 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021140 · doc4.xml · derivative · entry 9 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,887 Underlying: Common Stock · 104,363 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F8 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. F8 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:37 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 151,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021140 · doc4.xml · derivative · entry 8 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,666 Underlying: Common Stock · 151,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:37 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 71,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021140 · doc4.xml · derivative · entry 7 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 71,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:37 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionCommon Stock | 104,363 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021140 · doc4.xml · nonDerivative · entry 5 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,155,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:37 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionCommon Stock | 151,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021140 · doc4.xml · nonDerivative · entry 3 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,126,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:37 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionCommon Stock | 71,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021140 · doc4.xml · nonDerivative · entry 1 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,002,908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · balance_after: Includes 2,341 and 3,052 shares purchased under Issuer's Employee Stock Purchase Plan on 08/31/20 and 02/28/21, respectively. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:39 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 22,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021146 · doc4.xml · derivative · entry 9 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,230 Underlying: Common Stock · 22,770 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:39 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021146 · doc4.xml · derivative · entry 8 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:39 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 15,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021146 · doc4.xml · derivative · entry 7 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:39 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionCommon Stock | 22,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021146 · doc4.xml · nonDerivative · entry 5 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:39 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionCommon Stock | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021146 · doc4.xml · nonDerivative · entry 3 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:39 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionCommon Stock | 15,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021146 · doc4.xml · nonDerivative · entry 1 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:34 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 22,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021134 · doc4.xml · derivative · entry 8 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,230 Underlying: Common Stock · 22,770 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:34 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021134 · doc4.xml · derivative · entry 7 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:34 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 15,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021134 · doc4.xml · derivative · entry 6 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:34 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionCommon Stock | 22,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021134 · doc4.xml · nonDerivative · entry 4 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,965,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:34 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionCommon Stock | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021134 · doc4.xml · nonDerivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,958,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:34 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionCommon Stock | 15,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021134 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,913,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:29 UTC |
Jensen ChrystalChief Legal Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 22,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021131 · doc4.xml · derivative · entry 9 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,230 Underlying: Common Stock · 22,770 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F8 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. F8 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:29 UTC |
Jensen ChrystalChief Legal Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021131 · doc4.xml · derivative · entry 8 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.